Dopamine replacement remediates risk aversion in Parkinson's disease in a value-independent manner.
Parkinsonism Relat Disord
; 66: 189-194, 2019 09.
Article
in En
| MEDLINE
| ID: mdl-31473085
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Risk-Taking
/
Dopamine Agents
/
Levodopa
/
Decision Making
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Parkinsonism Relat Disord
Journal subject:
NEUROLOGIA
Year:
2019
Type:
Article